<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>immune resilience &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immune-resilience/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 13 Oct 2026 18:19:06 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>immune resilience &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Blood Test Clue: Monocyte Recovery During Glioblastoma Treatment Predicts Longer Survival</title>
		<link>https://bioengineer.org/blood-test-clue-monocyte-recovery-during-glioblastoma-treatment-predicts-longer-survival/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 13 Oct 2026 18:19:06 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[blood counts]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[corticosteroids]]></category>
		<category><![CDATA[Glioblastoma]]></category>
		<category><![CDATA[immune resilience]]></category>
		<category><![CDATA[MGMT methylation]]></category>
		<category><![CDATA[monocytes]]></category>
		<category><![CDATA[Neuro-oncology]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[survival]]></category>
		<category><![CDATA[temozolomide]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=417755</guid>

					<description><![CDATA[A new study finds that patients with IDH-wildtype glioblastoma whose circulating monocyte counts are preserved during chemoradiotherapy survive substantially longer, with the dynamic blood-based measure remaining independently prognostic after adjustment for established clinical factors.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">417755</post-id>	</item>
	</channel>
</rss>
